Clinical trial
Oxybutynin Chloride in Managing Hot Flashes
NCT02961790
Study timeline
Study start (actual)2016-12-09Date precision: day
Registry last updated2020-01-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Carcinomaunresolved
Ductal Breast Carcinoma In Situunresolved
Hot Flashesunresolved
Lobular Breast Carcinoma In Situunresolved
No Evidence of Diseaseunresolved
Interventions
Oxybutynin ChlorideDRUG · verified · RxNorm: oxybutynin chloride
PlaceboOTHER
Sponsors & collaborators
Academic and Community Cancer Research Unitedlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02961790 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.